A recent study showed that pharmacologic or genetic autophagy inhibition can synergistically enhance ERK inhibitor-induced cancer cell death in KRAS-driven pancreatic ductal adenocarcinoma 59. Here, KRAS is linked to pancreatic ductal adenocarcinoma.